Eaton, Jeffrey W <br/><br/>
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.  [electronic resource] 

 -  The Lancet. Global health  Jan 2014 
 - e23-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2214-109X 
<br/><br/><label>Standard No.: </label>10.1016/S2214-109X(13)70172-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active--economics<br/>CD4 Lymphocyte Count<br/>Cost-Benefit Analysis<br/>Eligibility Determination--methods<br/>Female<br/>HIV Infections--drug therapy<br/>Health Care Costs<br/>Humans<br/>India<br/>Male<br/>Models, Theoretical<br/>Quality-Adjusted Life Years<br/>South Africa<br/>Vietnam<br/>Zambia